慢性性ウルチカリアによるセリアック病の解明:症例報告と範囲のレビュー
Francesca Cappozzo1, Catarina Schrempp Esteves2, Fabio Corsolini3
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, 16146 Genoa, Italy.
Nutrients
|February 13, 2026
まとめ
セリアック疾患 (CD) は,慢性性ウルチカリア (CU) としてのみ現れます. グルテンフリーダイエット (GFD) は,小児患者のCUを効果的に解決し,GFDがCD患者のCUの潜在的な治療法であることを示唆しています.
科学分野:
- 胃腸内科 胃腸内科
- 免疫学 免疫学とは
- 皮膚科 皮膚科について
背景:
- セリアック疾患 (CD) は,様々な表れを持つ免疫媒介性腸病です.
- 慢性性下痢症 (CU) は,皮質疾患であり,しばしば自己病的であるが,自己免疫的な関連が浮上している.
- CDとCUの関係については,さらなる調査が必要である.
研究 の 目的:
- 慢性性ウルチカリがセリアック病の唯一の表れである可能性を調査する.
- CU患者におけるCDの罹患率を評価する.
- グルテンフリーダイエット (GFD) の治療効果をCUで評価する.
主な方法:
- 唯一のCD症状としてCUと血管腫の小児症例研究.
- CU患者におけるCD流行に関するスコーピング文献レビュー.
- GFDによる治療結果の分析.
主要な成果:
- Pediatric CUはGFDで迅速に解決し,CDマーカーを正常化しました.
- 文献は,CU患者におけるCDのより高い罹患率を確認しています.
- ケースレポートでは,GFDの開始後にCUの免除が示されています.
結論:
- 慢性性性ウルチカリアは,セリアック病の特有な臨床的兆候である可能性があります.
- CU患者のCDのスクリーニング,特に自己免疫機能または耐火性疾患を有する患者のスクリーニングは正当化されています.
- GFDは,CUの症状を迅速に改善し,薬剤の必要性を軽減し,生活の質を向上させることができます.
関連する概念動画
The Scope of Physics
53.7K
Physics is concerned with the interactions of energy, matter, space, and time, in order to discover the underlying mechanisms that underpin all phenomena. The word "physics" comes from the Greek word "phúsis", which means nature. Physics seeks to comprehend the natural world around us at its most fundamental level. It emphasizes the use of quantitative laws to do this, which could be valuable in other fields that want to push the performance boundaries of present...
53.7K
Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Kidney Disease I: Introduction
768
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
768
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
Chronic Kidney Disease II: Clinical Manifestations
688
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
688


